<DrugInformationSummary id="CDR0000776980"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about osimertinib mesylate
         and a collection of links to more information about the use of 
         this drug, research results, and ongoing clinical trials.
  </DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/osimertinib">Osimertinib Mesylate</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000747632">osimertinib</TerminologyLink><GlossaryLink ref="CDR0000776961">osimertinib mesylate</GlossaryLink><USBrandNames><USBrandName>Tagrisso</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>OH-sih-MER-tih-nib MEH-zih-layt</TermPronunciation><MediaLink ref="CDR0000778399" type="audio/mpeg" alt="" language="en" id="_5"/><MediaLink ref="CDR0000778398" type="audio/mpeg" alt="" language="es" id="_6"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Osimertinib Mesylate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Osimertinib mesylate
         is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000045323" dictionary="Cancer.gov" audience="Patient">Non-small cell lung cancer</GlossaryTermRef></Strong>  that has an abnormal <GeneName><GlossaryTermRef href="CDR0000796876" dictionary="Cancer.gov" audience="Patient">EGFR</GlossaryTermRef></GeneName> gene. It is used in adults:<ItemizedList Style="bullet" id="_5"><ListItem>who have had surgery to remove the cancer, to help keep the cancer from coming back after surgery </ListItem><ListItem>with <GlossaryTermRef href="CDR0000045367" dictionary="Cancer.gov" audience="Patient">stage IIIA</GlossaryTermRef>, <GlossaryTermRef href="CDR0000682421" dictionary="Cancer.gov" audience="Patient">stage IIIB</GlossaryTermRef>, or  <GlossaryTermRef href="CDR0000793422" dictionary="Cancer.gov" audience="Patient">stage IIIC</GlossaryTermRef> cancer  that cannot be removed by surgery and did not get worse during or after
<GlossaryTermRef href="CDR0000045841" dictionary="Cancer.gov" audience="Patient">platinum</GlossaryTermRef>-based <GlossaryTermRef href="CDR0000306495" dictionary="Cancer.gov" audience="Patient">chemoradiation therapy</GlossaryTermRef></ListItem><ListItem>as the first treatment for cancer that has spread to other parts of the body</ListItem><ListItem>with <GlossaryTermRef href="CDR0000045456" dictionary="Cancer.gov" audience="Patient">pemetrexed disodium</GlossaryTermRef> and platinum-based chemotherapy as the first treatment  for cancer that has spread to other parts of the body</ListItem><ListItem>with cancer that has spread to other parts of the body and got worse during or after treatment with another <GlossaryTermRef href="CDR0000491502" dictionary="Cancer.gov" audience="Patient">EGFR tyrosine kinase inhibitor</GlossaryTermRef></ListItem></ItemizedList></ListItem>
   
   </ItemizedList>
  <Para id="_4">Osimertinib mesylate
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Osimertinib Mesylate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/747632">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.38">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a616005.html">Osimertinib Mesylate</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.39"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.40">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2023/osimertinib-lung-cancer-adaura">Lung Cancer Trial of Osimertinib Draws Praiseâ€”and Some Criticism</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/kras-targeted-drugs-as-immunotherapy">Can Targeted Therapy for KRAS Mutations Double as Part of Immunotherapy?</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C116377">Find Clinical Trials for Osimertinib</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2015-11-23</DateFirstPublished><DateLastModified>2024-09-30</DateLastModified></DrugInformationSummary>
